SymBio Pharmaceuticals Limited
Status: Publicly traded
Direct answer
SymBio Pharmaceuticals Limited is publicly traded on JPX under the ticker 4582.T.
SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was...
Can you invest in SymBio Pharmaceuticals Limited?
Yes. SymBio Pharmaceuticals Limited is publicly traded on JPX under the ticker 4582.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for SymBio Pharmaceuticals Limited
Detailed equity research is provided by MarketSnap.